Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon.

Autor: Lew TE; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Bennett R; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia., Lin VS; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Whitechurch A; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia., Handunnetti SM; Department of Hematology, Princess Alexandra Hospital, Brisbane, QLD, Australia., Marlton P; Department of Hematology, Princess Alexandra Hospital, Brisbane, QLD, Australia.; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia., Shen Y; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia., Mulligan SP; Department of Haematology, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia.; Department of Haematology and Flow Cytometry, Laverty Pathology, Sydney, NSW, Australia., Casan J; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia., Blombery P; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Tam CS; Alfred Hospital and Monash University, Melbourne, VIC, Australia., Roberts AW; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Seymour JF; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Thompson PA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia., Anderson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.; Blood Cells and Blood Cancer Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.

Publikováno v: Blood advances [Blood Adv] 2024 Mar 26; Vol. 8 (6), pp. 1439-1443.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma.

Autor: Ratnasingam S; Department of Haematology, Monash Health, Melbourne, Australia.; Department of Haematology, Andrew Love Cancer Centre, University Hospital Geelong, Geelong, Australia., Casan J; Department of Haematology, Monash Health, Melbourne, Australia. Joshua.casan@monashhealth.org.; School of Clinical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Joshua.casan@monashhealth.org., Shortt J; Department of Haematology, Monash Health, Melbourne, Australia.; School of Clinical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia., Hawkes E; Department of Medical Oncology and Clinical Haematology, Olivia Newton John Cancer and Wellness Centre, Austin Hospital, Melbourne, Australia.; Department of Medical Oncology, Eastern Health, Melbourne, Australia., Gilbertson M; Department of Haematology, Monash Health, Melbourne, Australia., McQuilten Z; Department of Haematology, Monash Health, Melbourne, Australia., Grigoriadis G; Department of Haematology, Monash Health, Melbourne, Australia.; Department of Haematology, Alfred Health, Melbourne, Australia.; School of Clinical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia., Htun KT; Department of Haematology, Alfred Health, Melbourne, Australia., Htet SM; Department of Haematology, Andrew Love Cancer Centre, University Hospital Geelong, Geelong, Australia., Campbell P; Department of Haematology, Andrew Love Cancer Centre, University Hospital Geelong, Geelong, Australia., Chai KL; Department of Haematology, St Vincent's Hospital, Melbourne, Australia., Quach H; Department of Haematology, St Vincent's Hospital, Melbourne, Australia., Patil S; Department of Haematology, Alfred Health, Melbourne, Australia., Opat S; Department of Haematology, Monash Health, Melbourne, Australia.; School of Clinical Sciences, Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia.

Publikováno v: Scientific reports [Sci Rep] 2019 Sep 19; Vol. 9 (1), pp. 13544. Date of Electronic Publication: 2019 Sep 19.

Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant.

Autor: Tiong M; Department of Renal Medicine, Alfred Health, Melbourne, Victoria, Australia., Casan J; Department of Haematology, Alfred Health, Melbourne, Victoria, Australia., McLean C; Department of Anatomical Pathology, Alfred Health, Melbourne, Victoria, Australia.; Victorian Neuromuscular Laboratory Service, Alfred Health, Melbourne, Victoria, Australia.; Victorian Brain Bank, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.; The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.; Central Clinical School, Monash University, Clayton, Victoria, Australia.

Publikováno v: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2019 Apr; Vol. 21 (2), pp. e13045. Date of Electronic Publication: 2019 Jan 11.